Concepedia

Tasso Miliotis

TM

Statistics

Publications

30

Citations

2.4K

H-Index

24

Active since

1996

Affiliations

AstraZeneca (Sweden)(Current)

Lund University

Karolinska Institutet

University of Groningen

University of Gothenburg

Tasso Miliotis is an author at AstraZeneca (Sweden) specializing in medicine, mass spectrometry, and analytical chemistry.

ORCID

Top concepts

Publications per year

1996–2023

30

Publications

30

Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples

Karin Björhall, Tasso Miliotis, Pia Davidsson · PROTEOMICS · 2005 · 385 citations · Full text

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study

Jan W. Eriksson, Per Lundkvist, Per‐Anders Jansson et al. · Diabetologia · 2018 · 368 citations · Full text

An Automated On-Line Multidimensional HPLC System for Protein and Peptide Mapping with Integrated Sample Preparation

Knut Wagner, Tasso Miliotis, György Marko‐Varga et al. · Analytical Chemistry · 2002 · 259 citations

SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice

Damilola D. Adingupu, Sven Göpel, Julia Grönros et al. · Cardiovascular Diabetology · 2019 · 156 citations · Full text

Protein mapping by two-dimensional high performance liquid chromatography

Karl‐Heinz Wagner, K. Racaityte, Klaus K. Unger et al. · Journal of Chromatography A · 2000 · 146 citations

, , +5

1–5 of 30